Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maes

Showing results (251-260 of 283) with videos related to

Pageof 29
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksL J van Warmerdam, J Verweij, J H Schellens, et al.
Seminars in Oncology|June 8, 2001
Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcomeH Dumez, M Highley, G Guetens, et al.
The American Journal of Pathology|December 1, 1996
CD40 is a prognostic marker in primary cutaneous malignant melanomaJ J van den Oord, A Maes, M Stas, et al.
Journal of Chromatography. A|December 15, 2004
Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometryMichelle Wood, Marleen Laloup, Nele Samyn, et al.
Circulation|January 13, 1999
Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular functionJ Bogaert, A Maes, F Van de Werf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionL J van Warmerdam, W W ten Bokkel Huinink, S Rodenhuis, et al.
Anti-Cancer Drugs|December 13, 2006
Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic studyHerlinde Dumez, Marc Martens, Johan Selleslach, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 23, 2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancerP Flamen, A Lerut, E Van Cutsem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1996
Three-dimensional correction for spillover and recovery of myocardial PET imagesH Nuyts, A Maes, M Vrolix, et al.
Radiation Research|May 4, 2006
Investigation of co-genotoxic effects of radiofrequency electromagnetic fields in vivoL Verschaeve, P Heikkinen, G Verheyen, et al.
Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksL J van Warmerdam, J Verweij, J H Schellens, et al.
Seminars in Oncology|June 8, 2001
Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcomeH Dumez, M Highley, G Guetens, et al.
The American Journal of Pathology|December 1, 1996
CD40 is a prognostic marker in primary cutaneous malignant melanomaJ J van den Oord, A Maes, M Stas, et al.
Journal of Chromatography. A|December 15, 2004
Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometryMichelle Wood, Marleen Laloup, Nele Samyn, et al.
Circulation|January 13, 1999
Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular functionJ Bogaert, A Maes, F Van de Werf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionL J van Warmerdam, W W ten Bokkel Huinink, S Rodenhuis, et al.
Anti-Cancer Drugs|December 13, 2006
Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic studyHerlinde Dumez, Marc Martens, Johan Selleslach, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 23, 2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancerP Flamen, A Lerut, E Van Cutsem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1996
Three-dimensional correction for spillover and recovery of myocardial PET imagesH Nuyts, A Maes, M Vrolix, et al.
Radiation Research|May 4, 2006
Investigation of co-genotoxic effects of radiofrequency electromagnetic fields in vivoL Verschaeve, P Heikkinen, G Verheyen, et al.
Pageof 29